secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cingulate Inc. (CING)
CIK:        0001862150
Form:       8-K
Filed at:   2024-10-07T23:59:59+00:00
Accession:  0001493152-24-039645
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Cingulate raises $11.7M, extends cash runway through Q2 2025; NDA for CTx-1301 targeted mid-2025
--------------------------------------------------------------------------------

- Raised approximately $11.7 million in capital during August and September 2024.
- Cash and cash equivalents of approximately $10 million as of September 30, 2024.
- Cash runway extended through second quarter of 2025 to fund clinical, manufacturing, and regulatory activities.
- NDA filing for CTx-1301 targeting mid-2025 for potential FDA approval.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1862150/000149315224039645/0001493152-24-039645-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1862150/000149315224039645/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-039645

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer